|
|
| | L-Cysteine, S-[[3-[[(2-aminoethyl)thio]methyl]-5-(mercaptomethyl)phenyl]methyl]-N-(1-oxohexyl)-L-cysteinyl-L-prolyl-L-prolyl-L-threonyl-L-glutaminyl-L-phenylalanyl-, cyclic (1→7)-thioether Basic information |
| | L-Cysteine, S-[[3-[[(2-aminoethyl)thio]methyl]-5-(mercaptomethyl)phenyl]methyl]-N-(1-oxohexyl)-L-cysteinyl-L-prolyl-L-prolyl-L-threonyl-L-glutaminyl-L-phenylalanyl-, cyclic (1→7)-thioether Chemical Properties |
| Boiling point | 1429.1±65.0 °C(Predicted) | | density | 1.37±0.1 g/cm3(Predicted) | | pka | 3.04±0.70(Predicted) |
| | L-Cysteine, S-[[3-[[(2-aminoethyl)thio]methyl]-5-(mercaptomethyl)phenyl]methyl]-N-(1-oxohexyl)-L-cysteinyl-L-prolyl-L-prolyl-L-threonyl-L-glutaminyl-L-phenylalanyl-, cyclic (1→7)-thioether Usage And Synthesis |
| Uses | 3BP-4089 is a highly potent fibroblast activation protein (FAP)-targeting peptide for theranostics. 3BP-4089 is often coupled with radionuclides for tumor diagnosis and research[1]. | | References | [1] Frank Osterkamp, et al. Compounds comprising a fibroblast activation protein ligand and use thereof. WO2021005131A1. 2021 January 14. |
| | L-Cysteine, S-[[3-[[(2-aminoethyl)thio]methyl]-5-(mercaptomethyl)phenyl]methyl]-N-(1-oxohexyl)-L-cysteinyl-L-prolyl-L-prolyl-L-threonyl-L-glutaminyl-L-phenylalanyl-, cyclic (1→7)-thioether Preparation Products And Raw materials |
|